Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities    
Net income (loss) $ 47 $ (75)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 66 19
Amortization of debt issuance costs, deferred commitment fees, premium and discount 10 4
Loss on early extinguishment of debt 42 1
Total losses on derivatives, net 39 25
Net cash used for settlement of derivative instruments (13) (3)
Changes in operating assets and liabilities:    
Accounts and other receivables (11) 0
Accounts receivable—affiliate 59 1
Advances to affiliate (41) (1)
Inventory 17 0
Accounts payable and accrued liabilities (38) 34
Due to affiliates (68) (8)
Deferred revenue (11) (1)
Other, net 1 (2)
Other, net—affiliate 16 0
Net cash provided by (used in) operating activities 115 (6)
Cash flows from investing activities    
Property, plant and equipment, net (524) (715)
Other 0 (34)
Net cash used in investing activities (524) (749)
Cash flows from financing activities    
Proceeds from issuances of debt 2,314 1,235
Repayments of debt (703) (415)
Debt issuance and deferred financing costs (26) (48)
Distributions to owners (25) (25)
Net cash provided by financing activities 1,560 747
Net increase (decrease) in cash, cash equivalents and restricted cash 1,151 (8)
Cash, cash equivalents and restricted cash—beginning of period 605 434
Cash, cash equivalents and restricted cash—end of period 1,756 426
Balances per Consolidated Balance Sheets:    
Cash and cash equivalents 0 10
Restricted cash 756 402
Non-current restricted cash 1,000 14
Total cash, cash equivalents and restricted cash $ 1,756 $ 426